Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

Ascelia Pharma - Podcast with Deputy CEO Julie Waras Brogren and CSO Andreas Norlin

Af Claus ThestrupCEO, Sweden
Ascelia Pharma

We have sat down with Ascelia Pharma Deputy CEO Julie Waras Brogren and CSO Andreas Norlin. In this podcast, we are covering the following topics:

Warrant TO1 - Exercise period ongoing:  Subscription period, price, and price calculation. What are gross proceeds at 100% participation?

Feedback from presenting Orviglance abstracts at scientific conferences: RSNA, Society of Abdominal Radiology Congress, ESGAR, ISPOR. What kind of feedback do you receive from the scientific community ie. clinicians, physicians, and KOL?  Do payers, policymakers, healthcare providers, patient organizations, and industry players participate?

Discussions with the FDA: Ascelia Pharma received a positive outcome from the FDA and are ready to file their NDA in mid-2025. What is the format when you discuss with the FDA?

Disclaimer: HC Andersen Capital receives payment from Ascelia Pharam for a Corporate Visibility/Digital IR subscription agreement. /Claus Thestrup, 11.24 AM, 11 April 2025.

Seneste videoer

Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025, 12.50 Orion
AKTIER MED FRIIS - UGE 50 2025
12.12.2025, 12.00
HCA Morgenbørs 12/12 - Positive futures og fokus på FLSmidth og fedme aktier
12.12.2025, 09.27 Novo Nordisk
A sit-down with CEO Remco Westermann
12.12.2025, 09.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025, 11.00 Aiforia Technologies
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.